Latest VNDA reports update at 2024-02-08: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Vanda Pharmaceuticals
  4. Financial Ratios
Vanda Pharmaceuticals logo
Vanda Pharmaceuticals VNDA
$ 5.01 -6.53%
mail-toReport an Error

Vanda Pharmaceuticals Financial Ratios 2011-2024 | VNDA

Annual Financial Ratios Vanda Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 92.9 65.8 26.3 30.6 6.0 56.9 -46.6 -32.1 -9.0 19.2 -19.6 -4.4 -14.1

P/S

 1.2 1.6 3.2 2.9 3.0 7.4 4.4 4.0 3.3 7.7 11.7 3.7 4.4

EPS

 0.0 0.1 0.6 0.4 2.2 0.5 -0.3 -0.4 -0.9 0.6 -0.7 -1.0 -0.3

EV (Enterprise Value)

 201 M 385 M 908 M 734 M 719 M 1.43 B 765 M 616 M 390 M 337 M 431 M 159 M 200 M

EBITDA per Share

 -0.23 0.13 0.78 0.53 0.458 0.457 -0.339 -0.176 -0.644 -1.59 -0.623 -0.947 -0.328

EV/EBITDA

 20.0 26.1 26.6 59.0 -45.6 -70.4 -11.4 -5.9 -17.5 -1.3 -5.5

PEG

 -1.56 -1.29 -1.66 -0.77 0.02 0.23 -3.18 -0.57 0.03 0.1 -0.62 0.02 0.06

P/B

 0.4 0.8 1.7 1.6 1.7 5.2 5.5 4.4 2.7 2.4 9.0 12.4 4.1

P/CF

 18.2 12.9 13.6 13.8 15.4 310.6 -198.7 -60.8 36.3 -4.3 -10.0 -2.6 -4.8

ROE %

 0.46 1.19 6.57 5.15 28.12 9.15 -11.85 -13.71 -29.97 12.55 -45.90 -279.29 -29.28

ROA %

 0.39 0.99 5.58 4.37 23.89 7.59 -7.58 -8.56 -18.71 11.76 -14.13 -20.42 -5.37

ROCE %

 -2.56 1.20 8.35 6.01 5.38 7.79 -12.51 -11.60 -24.85 -35.11 -18.46 -27.35 -7.09

Current Ratio

 6.3 5.9 6.7 6.7 6.0 5.6 2.4 3.5 3.2 18.2 4.1 3.9 4.9

DSO

 64.1 47.3 42.5 41.5 42.4 54.4 38.9 50.7 54.2 26.6 23.3 16.1 18.9

DIO

 31.5 16.7 16.4 18.9 17.0 17.7 17.2 11.5 20.1 1134.0 - 161.3 -

DPO

 - - - - - - 415.9 239.2 245.3 192.5 - 812.1 -

Operating Cycle

 95.6 64.0 58.9 60.4 59.4 72.1 56.1 62.2 74.4 1160.6 - 177.4 -

Cash Conversion Cycle

 95.6 64.0 58.9 60.4 59.4 72.1 -359.8 -177.0 -170.9 968.0 - -634.7 -

All numbers in USD currency

Quarterly Financial Ratios Vanda Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 - 0.03 0.06 - 0.06 0.05 -0.11 - 0.14 0.17 0.16 0.15 0.11 0.16 0.01 0.08 1.88 0.22 -0.01 0.2 0.14 0.09 0.07 -0.04 -0.1 -0.03 -0.17 -0.01 -0.01 -0.11 -0.29 -0.35 -0.22 -0.13 -0.24 1.85 -0.04 -0.64 -0.79 -0.23 -0.17 -0.11 -0.15 -0.23 -0.19 -0.28 -0.28 -0.2 -0.11 -0.05 -

EBITDA per Share

 -0.1 -0.04 0.04 - 0.08 0.07 -0.13 - 0.21 0.23 0.19 0.19 0.16 0.18 - 0.08 0.22 0.2 -0.03 0.17 0.14 0.09 0.06 -0.05 -0.09 -0.03 -0.17 -0.01 - -0.1 -0.28 -0.35 -0.21 -0.12 -0.24 1.68 -0.03 -0.63 -0.79 -0.23 -0.16 -0.11 -0.16 -0.23 -0.17 -0.27 -0.28 -0.21 -0.11 -0.05 -

ROE %

 1.55 2.16 2.38 -0.14 1.43 2.38 3.88 5.43 7.24 6.97 6.89 5.15 4.37 27.49 28.37 28.12 30.85 9.02 7.89 9.15 3.99 -2.07 -4.92 -11.85 -10.91 -7.77 -10.12 -13.71 -24.38 -31.16 -31.69 -29.97 24.51 30.73 21.37 12.55 -48.36 -59.72 -53.98 -47.72 -94.46 -135.98 -209.15 -279.29 -231.49 -186.90 -110.07 -29.28 -9.18 -4.01 0.41

ROA %

 1.29 1.79 0.49 -1.60 -0.26 1.62 3.32 4.63 6.17 5.94 5.88 4.37 3.71 23.36 24.10 23.89 26.13 7.53 6.54 7.59 3.58 -0.80 -2.93 -7.58 -6.97 -4.96 -6.41 -8.56 -15.22 -19.46 -19.79 -18.71 28.84 32.45 22.41 11.76 -34.25 -37.19 -26.99 -14.69 -13.99 -14.15 -17.70 -20.42 -18.75 -16.50 -11.32 -5.37 -1.68 -0.73 0.07

ROCE %

 -0.50 1.36 2.57 -0.09 2.10 3.54 5.43 6.97 9.28 8.80 8.25 6.01 4.74 5.65 6.03 5.55 7.84 7.49 6.50 7.89 2.93 -3.08 -5.96 -12.87 -11.73 -8.48 -10.66 -14.14 -24.84 -31.51 -31.97 -30.21 24.32 30.60 21.26 12.47 -48.52 -59.93 -54.23 -48.05 -95.29 -137.44 -211.34 -284.96 -237.71 -193.08 -115.97 -31.99 -9.84 -4.52 0.02

Current Ratio

 6.5 6.3 5.9 5.9 5.9 - 6.0 6.7 6.7 6.6 7.2 6.7 6.7 6.7 6.7 6.6 6.6 6.6 6.6 5.9 5.9 5.9 5.9 2.8 2.8 2.8 2.8 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 15.8 15.8 15.8 15.8 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.2 1.2 1.2 1.2

DSO

 73.9 57.6 42.4 - 20.5 21.6 47.7 - 51.1 46.1 44.8 40.5 45.5 44.1 44.4 39.5 40.5 40.7 52.7 49.5 53.5 55.5 48.5 36.3 38.9 38.2 46.2 48.4 48.1 51.3 50.2 46.8 52.6 54.0 41.2 21.7 22.6 30.7 28.4 21.1 21.3 22.3 18.1 13.5 12.9 12.7 15.6 17.6 18.5 19.9 -

DIO

 31.1 28.5 22.0 - 11.5 9.7 18.6 - 13.1 16.8 20.0 - 19.8 20.0 21.2 - 15.3 16.3 19.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 105.0 86.1 64.3 - 32.0 31.3 66.4 - 64.3 62.9 64.8 40.5 65.2 64.0 65.6 39.5 55.8 57.1 71.8 49.5 53.5 55.5 48.5 36.3 38.9 38.2 46.2 48.4 48.1 51.3 50.2 46.8 52.6 54.0 41.2 21.7 22.6 30.7 28.4 21.1 21.3 22.3 18.1 13.5 12.9 12.7 15.6 17.6 18.5 19.9 -

Cash Conversion Cycle

 105.0 86.1 64.3 - 32.0 31.3 66.4 - 64.3 62.9 64.8 40.5 65.2 64.0 65.6 39.5 55.8 57.1 71.8 49.5 53.5 55.5 48.5 36.3 38.9 38.2 46.2 48.4 48.1 51.3 50.2 46.8 52.6 54.0 41.2 21.7 22.6 30.7 28.4 21.1 21.3 22.3 18.1 13.5 12.9 12.7 15.6 17.6 18.5 19.9 -

All numbers in USD currency